PARATEK PHARMACEUTICALS
Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. Paratek's lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed in both oral tablet and intravenous formulations for use as a first-line monotherapy antibiotic for ABSSSI, CABP, urinary tract infections (UTI) and other serious community-acquired bacte... rial infections, particularly when antibiotic resistance is of concern to prescribing physicians. Omadacycline has received Qualified Infectious Disease Product (QIDP) designation by the U.S. Food and Drug Administration for both the oral and intravenous formulations in all three of these infectious disease categories. Paratek has Special Protocol Assessment agreements with the FDA for the phase 3 trials planned in ABSSSI and CABP.
PARATEK PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care
Founded:
1996-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.paratekpharma.com
Total Employee:
101+
Status:
Active
Contact:
(617)807-6600
Email Addresses:
[email protected]
Total Funding:
133 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Microsoft Exchange Online
Similar Organizations
Akari Therapeutics
Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
resTORbio
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-10-30 | Transcept Pharmaceuticals | Transcept Pharmaceuticals acquired by Paratek Pharmaceuticals | N/A |
Investors List
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Post-IPO Equity - Paratek Pharmaceuticals
Omega Funds
Omega Funds investment in Post-IPO Debt - Paratek Pharmaceuticals
Aisling Capital
Aisling Capital investment in Post-IPO Debt - Paratek Pharmaceuticals
Abingworth
Abingworth investment in Post-IPO Debt - Paratek Pharmaceuticals
The Baupost Group
The Baupost Group investment in Post-IPO Debt - Paratek Pharmaceuticals
Aisling Capital
Aisling Capital investment in Post-IPO Equity - Paratek Pharmaceuticals
Pacific Growth Equities
Pacific Growth Equities investment in Post-IPO Equity - Paratek Pharmaceuticals
D. E. Shaw & Co.
D. E. Shaw & Co. investment in Post-IPO Equity - Paratek Pharmaceuticals
IBT Management Corporation
IBT Management Corporation investment in Post-IPO Equity - Paratek Pharmaceuticals
Official Site Inspections
http://www.paratekpharma.com Semrush global rank: 3.43 M Semrush visits lastest month: 4.5 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
